Jenssen noted that precautions for SGLT2 inhibitors in patients with PTDM include genitourinary tract infections, ketoacidosis and decreased renal function, including acute kidney injury (AKI) due to dehydration associated with increased urinary glucose. This evidence concerns the gene SLC5A2 and acute kidney injury.